DOCSLIB.ORG

Mouse Rps6ka5 Antibody (C-Term) Purified Rabbit Polyclonal Antibody (Pab) Catalog # AW5466

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Mouse Rps6ka5 Antibody (C-Term) Purified Rabbit Polyclonal Antibody (Pab) Catalog # AW5466 10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609 Mouse Rps6ka5 Antibody (C-term) Purified Rabbit Polyclonal Antibody (Pab) Catalog # AW5466 Specification Mouse Rps6ka5 Antibody (C-term) - Product Information Application WB,E Primary Accession Q8C050 Reactivity Mouse Host Rabbit Clonality Polyclonal Calculated MW M=97,90 KDa Isotype Rabbit Ig Antigen Source HUMAN Mouse Rps6ka5 Antibody (C-term) - Additional Information Gene ID 73086 Antigen Region All lanes : Anti-Rps6ka5 Antibody (C-term) at 850-883 1:1000 dilution Lane 1: L929 whole cell Other Names lysates Lane 2: mouse spleen lysates Lane 3: Ribosomal protein S6 kinase alpha-5, mouse thymus lysates Lysates/proteins at 20 S6K-alpha-5, 90 kDa ribosomal protein S6 µg per lane. Secondary Goat Anti-Rabbit IgG, kinase 5, Nuclear mitogen- and (H+L),Peroxidase conjugated at 1/10000 stress-activated protein kinase 1, RSK-like dilution Predicted band size : 97 kDa protein kinase, RLSK, Rps6ka5, Msk1 Blocking/Dilution buffer: 5% NFDM/TBST. Dilution WB~~1:1000 Mouse Rps6ka5 Antibody (C-term) - Background Target/Specificity This Mouse Rps6ka5 antibody is generated Serine/threonine-protein kinase that is from a rabbit immunized with a KLH required for the mitogen or stress-induced conjugated synthetic peptide between phosphorylation of the transcription factors 850-883 amino acids from the C-terminal CREB1 and ATF1 and for the regulation of the region of Mouse Rps6ka5. transcription factors RELA, STAT3 and ETV1/ER81, and that contributes to gene Format activation by histone phosphorylation and Purified polyclonal antibody supplied in PBS functions in the regulation of inflammatory with 0.09% (W/V) sodium azide. This genes. Phosphorylates CREB1 and ATF1 in antibody is purified through a protein A response to mitogenic or stress stimuli such as column, followed by peptide affinity UV-C irradiation, epidermal growth factor (EGF) purification. and anisomycin. Plays an essential role in the control of RELA transcriptional activity in Storage response to TNF and upon glucocorticoid, Maintain refrigerated at 2-8°C for up to 2 associates in the cytoplasm with the weeks. For long term storage store at -20°C glucocorticoid receptor NR3C1 and contributes Page 1/4 10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609 in small aliquots to prevent freeze-thaw to RELA inhibition and repression of cycles. inflammatory gene expression. In skeletal myoblasts is required for phosphorylation of Precautions RELA at &apos;Ser-276&apos; during oxidative Mouse Rps6ka5 Antibody (C-term) is for stress. In erythropoietin-stimulated cells, is research use only and not for use in necessary for the &apos;Ser-727&apos; diagnostic or therapeutic procedures. phosphorylation of STAT3 and regulation of its transcriptional potential. Phosphorylates ETV1/ER81 at &apos;Ser-191&apos; and Mouse Rps6ka5 Antibody (C-term) - Protein &apos;Ser-216&apos;, and thereby regulates Information its ability to stimulate transcription, which may be important during development and breast Name Rps6ka5 tumor formation. Directly represses transcription via phosphorylation of Synonyms Msk1 &apos;Ser-1&apos; of histone H2A. Phosphorylates &apos;Ser-10&apos; of histone Function H3 in response to mitogenics, stress stimuli Serine/threonine-protein kinase that is and EGF, which results in the transcriptional required for the mitogen or stress-induced activation of several immediate early genes, phosphorylation of the transcription factors including proto- oncogenes c-fos/FOS and CREB1 and ATF1 and for the regulation of c-jun/JUN. May also phosphorylate the transcription factors RELA, STAT3 and &apos;Ser-28&apos; of histone H3. Mediates ETV1/ER81, and that contributes to gene the mitogen- and stress-induced activation by histone phosphorylation and phosphorylation of high mobility group protein functions in the regulation of inflammatory 1 (HMGN1/HMG14). In genes (By similarity)(PubMed:<a href="http lipopolysaccharide-stimulated primary ://www.uniprot.org/citations/11553624" macrophages, acts downstream of the Toll-like target="_blank">11553624</a>, PubMed:<a href="http://www.uniprot.org/ci receptor TLR4 to limit the production of pro- tations/11909979" inflammatory cytokines. Functions probably by target="_blank">11909979</a>, inducing transcription of the MAP kinase PubMed:<a href="http://www.uniprot.org/ci phosphatase DUSP1 and the anti- tations/16806820" inflammatory cytokine interleukin 10 (IL10), via target="_blank">16806820</a>). CREB1 and ATF1 transcription factors. Plays a Phosphorylates CREB1 and ATF1 in role in neuronal cell death by mediating the response to mitogenic or stress stimuli such downstream effects of excitotoxic injury. as UV-C irradiation, epidermal growth factor (EGF) and anisomycin (PubMed:<a href="ht Mouse Rps6ka5 Antibody (C-term) - tp://www.uniprot.org/citations/11909979" References target="_blank">11909979</a>). Plays an essential role in the control of RELA Zhou G.,et al.Submitted (JUL-2003) to the transcriptional activity in response to TNF EMBL/GenBank/DDBJ databases. and upon glucocorticoid, associates in the Carninci P.,et al.Science 309:1559-1563(2005). cytoplasm with the glucocorticoid receptor Zhong S.,et al.J. Biol. Chem. NR3C1 and contributes to RELA inhibition 276:33213-33219(2001). and repression of inflammatory gene Zhang Y.,et al.J. Biol. Chem. expression (PubMed:<a href="http://www.u 276:42534-42542(2001). niprot.org/citations/12628924" Wiggin G.R.,et al.Mol. Cell. Biol. target="_blank">12628924</a>, 22:2871-2881(2002). PubMed:<a href="http://www.uniprot.org/ci tations/16806820" target="_blank">16806820</a>). In skeletal myoblasts is required for phosphorylation of RELA at 'Ser-276' during oxidative stress (PubMed:<a href="http://w ww.uniprot.org/citations/12628924" target="_blank">12628924</a>). In Page 2/4 10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609 erythropoietin-stimulated cells, is necessary for the 'Ser-727' phosphorylation of STAT3 and regulation of its transcriptional potential (PubMed:<a href="http://www.uni prot.org/citations/11553624" target="_blank">11553624</a>). Phosphorylates ETV1/ER81 at 'Ser-191' and 'Ser-216', and thereby regulates its ability to stimulate transcription, which may be important during development and breast tumor formation (By similarity). Directly represses transcription via phosphorylation of 'Ser-1' of histone H2A (By similarity). Phosphorylates 'Ser-10' of histone H3 in response to mitogenics, stress stimuli and EGF, which results in the transcriptional activation of several immediate early genes, including proto-oncogenes c-fos/FOS and c-jun/JUN (PubMed:<a href="http://ww w.uniprot.org/citations/15870105" target="_blank">15870105</a>, PubMed:<a href="http://www.uniprot.org/ci tations/16517600" target="_blank">16517600</a>). May also phosphorylate 'Ser-28' of histone H3 (PubMed:<a href="http://www.uniprot.org/c itations/11441012" target="_blank">11441012</a>, PubMed:<a href="http://www.uniprot.org/ci tations/15870105" target="_blank">15870105</a>). Mediates the mitogen- and stress-induced phosphorylation of high mobility group protein 1 (HMGN1/HMG14) (By similarity). In lipopolysaccharide- stimulated primary macrophages, acts downstream of the Toll-like receptor TLR4 to limit the production of pro-inflammatory cytokines (PubMed:<a href="http://www.uniprot.org/c itations/18690222" target="_blank">18690222</a>). Functions probably by inducing transcription of the MAP kinase phosphatase DUSP1 and the anti-inflammatory cytokine interleukin 10 (IL10), via CREB1 and ATF1 transcription factors (PubMed:<a href="http://www.unipr ot.org/citations/18690222" target="_blank">18690222</a>). Plays a role in neuronal cell death by mediating the downstream effects of excitotoxic injury (PubMed:<a href="http://www.uniprot.org/c itations/12807421" target="_blank">12807421</a>). Phosphorylates TRIM7 at 'Ser-106' in response to growth factor signaling via the MEK/ERK pathway, thereby stimulating its Page 3/4 10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609 ubiquitin ligase activity (By similarity). Cellular Location Nucleus. Mouse Rps6ka5 Antibody (C-term) - Protocols Provided below are standard protocols that you may find useful for product applications. • Western Blot • Blocking Peptides • Dot Blot • Immunohistochemistry • Immunofluorescence • Immunoprecipitation • Flow Cytomety • Cell Culture Page 4/4 Powered by TCPDF (www.tcpdf.org).
Load more

Recommended publications
  • Supplementary Table S1. Upregulated Genes Differentially
    Supplementary Table S1. Upregulated genes differentially expressed in athletes (p < 0.05 and 1.3-fold change) Gene Symbol p Value Fold Change 221051_s_at NMRK2 0.01 2.38 236518_at CCDC183 0.00 2.05 218804_at ANO1 0.00 2.05 234675_x_at 0.01 2.02 207076_s_at ASS1 0.00 1.85 209135_at ASPH 0.02 1.81 228434_at BTNL9 0.03 1.81 229985_at BTNL9 0.01 1.79 215795_at MYH7B 0.01 1.78 217979_at TSPAN13 0.01 1.77 230992_at BTNL9 0.01 1.75 226884_at LRRN1 0.03 1.74 220039_s_at CDKAL1 0.01 1.73 236520_at 0.02 1.72 219895_at TMEM255A 0.04 1.72 201030_x_at LDHB 0.00 1.69 233824_at 0.00 1.69 232257_s_at 0.05 1.67 236359_at SCN4B 0.04 1.64 242868_at 0.00 1.63 1557286_at 0.01 1.63 202780_at OXCT1 0.01 1.63 1556542_a_at 0.04 1.63 209992_at PFKFB2 0.04 1.63 205247_at NOTCH4 0.01 1.62 1554182_at TRIM73///TRIM74 0.00 1.61 232892_at MIR1-1HG 0.02 1.61 204726_at CDH13 0.01 1.6 1561167_at 0.01 1.6 1565821_at 0.01 1.6 210169_at SEC14L5 0.01 1.6 236963_at 0.02 1.6 1552880_at SEC16B 0.02 1.6 235228_at CCDC85A 0.02 1.6 1568623_a_at SLC35E4 0.00 1.59 204844_at ENPEP 0.00 1.59 1552256_a_at SCARB1 0.02 1.59 1557283_a_at ZNF519 0.02 1.59 1557293_at LINC00969 0.03 1.59 231644_at 0.01 1.58 228115_at GAREM1 0.01 1.58 223687_s_at LY6K 0.02 1.58 231779_at IRAK2 0.03 1.58 243332_at LOC105379610 0.04 1.58 232118_at 0.01 1.57 203423_at RBP1 0.02 1.57 AMY1A///AMY1B///AMY1C///AMY2A///AMY2B// 208498_s_at 0.03 1.57 /AMYP1 237154_at LOC101930114 0.00 1.56 1559691_at 0.01 1.56 243481_at RHOJ 0.03 1.56 238834_at MYLK3 0.01 1.55 213438_at NFASC 0.02 1.55 242290_at TACC1 0.04 1.55 ANKRD20A1///ANKRD20A12P///ANKRD20A2///
    [Show full text]
  • Phospho-RPS6KA5-T581 Rabbit Pab
    Leader in Biomolecular Solutions for Life Science Phospho-RPS6KA5-T581 Rabbit pAb Catalog No.: AP1197 Basic Information Background Catalog No. Serine/threonine-protein kinase that is required for the mitogen or stress-induced AP1197 phosphorylation of the transcription factors CREB1 and ATF1 and for the regulation of the transcription factors RELA, STAT3 and ETV1/ER81, and that contributes to gene Observed MW activation by histone phosphorylation and functions in the regulation of inflammatory Refer to figures genes (PubMed:11909979, PubMed:12569367, PubMed:12763138, PubMed:9687510, PubMed:18511904, PubMed:9873047). Phosphorylates CREB1 and ATF1 in response to Calculated MW mitogenic or stress stimuli such as UV-C irradiation, epidermal growth factor (EGF) and 61kDa/81kDa/89kDa anisomycin (PubMed:11909979, PubMed:9873047). Plays an essential role in the control of RELA transcriptional activity in response to TNF and upon glucocorticoid, associates in Category the cytoplasm with the glucocorticoid receptor NR3C1 and contributes to RELA inhibition and repression of inflammatory gene expression (PubMed:12628924, Primary antibody PubMed:18511904). In skeletal myoblasts is required for phosphorylation of RELA at 'Ser-276' during oxidative stress (PubMed:12628924). In erythropoietin-stimulated cells, Applications is necessary for the 'Ser-727' phosphorylation of STAT3 and regulation of its WB transcriptional potential (PubMed:12763138). Phosphorylates ETV1/ER81 at 'Ser-191' and 'Ser-216', and thereby regulates its ability to stimulate transcription, which may be Cross-Reactivity important during development and breast tumor formation (PubMed:12569367). Directly Human, Mouse, Rat represses transcription via phosphorylation of 'Ser-1' of histone H2A (PubMed:15010469). Phosphorylates 'Ser-10' of histone H3 in response to mitogenics, stress stimuli and EGF, which results in the transcriptional activation of several Recommended Dilutions immediate early genes, including proto-oncogenes c-fos/FOS and c-jun/JUN (PubMed:12773393).
    [Show full text]
  • Application of a MYC Degradation
    SCIENCE SIGNALING | RESEARCH ARTICLE CANCER Copyright © 2019 The Authors, some rights reserved; Application of a MYC degradation screen identifies exclusive licensee American Association sensitivity to CDK9 inhibitors in KRAS-mutant for the Advancement of Science. No claim pancreatic cancer to original U.S. Devon R. Blake1, Angelina V. Vaseva2, Richard G. Hodge2, McKenzie P. Kline3, Thomas S. K. Gilbert1,4, Government Works Vikas Tyagi5, Daowei Huang5, Gabrielle C. Whiten5, Jacob E. Larson5, Xiaodong Wang2,5, Kenneth H. Pearce5, Laura E. Herring1,4, Lee M. Graves1,2,4, Stephen V. Frye2,5, Michael J. Emanuele1,2, Adrienne D. Cox1,2,6, Channing J. Der1,2* Stabilization of the MYC oncoprotein by KRAS signaling critically promotes the growth of pancreatic ductal adeno- carcinoma (PDAC). Thus, understanding how MYC protein stability is regulated may lead to effective therapies. Here, we used a previously developed, flow cytometry–based assay that screened a library of >800 protein kinase inhibitors and identified compounds that promoted either the stability or degradation of MYC in a KRAS-mutant PDAC cell line. We validated compounds that stabilized or destabilized MYC and then focused on one compound, Downloaded from UNC10112785, that induced the substantial loss of MYC protein in both two-dimensional (2D) and 3D cell cultures. We determined that this compound is a potent CDK9 inhibitor with a previously uncharacterized scaffold, caused MYC loss through both transcriptional and posttranslational mechanisms, and suppresses PDAC anchorage- dependent and anchorage-independent growth. We discovered that CDK9 enhanced MYC protein stability 62 through a previously unknown, KRAS-independent mechanism involving direct phosphorylation of MYC at Ser .
    [Show full text]
  • Development and Validation of a Protein-Based Risk Score for Cardiovascular Outcomes Among Patients with Stable Coronary Heart Disease
    Supplementary Online Content Ganz P, Heidecker B, Hveem K, et al. Development and validation of a protein-based risk score for cardiovascular outcomes among patients with stable coronary heart disease. JAMA. doi: 10.1001/jama.2016.5951 eTable 1. List of 1130 Proteins Measured by Somalogic’s Modified Aptamer-Based Proteomic Assay eTable 2. Coefficients for Weibull Recalibration Model Applied to 9-Protein Model eFigure 1. Median Protein Levels in Derivation and Validation Cohort eTable 3. Coefficients for the Recalibration Model Applied to Refit Framingham eFigure 2. Calibration Plots for the Refit Framingham Model eTable 4. List of 200 Proteins Associated With the Risk of MI, Stroke, Heart Failure, and Death eFigure 3. Hazard Ratios of Lasso Selected Proteins for Primary End Point of MI, Stroke, Heart Failure, and Death eFigure 4. 9-Protein Prognostic Model Hazard Ratios Adjusted for Framingham Variables eFigure 5. 9-Protein Risk Scores by Event Type This supplementary material has been provided by the authors to give readers additional information about their work. Downloaded From: https://jamanetwork.com/ on 10/02/2021 Supplemental Material Table of Contents 1 Study Design and Data Processing ......................................................................................................... 3 2 Table of 1130 Proteins Measured .......................................................................................................... 4 3 Variable Selection and Statistical Modeling ........................................................................................
    [Show full text]
  • Cells Phenotype of Human Tolerogenic Dendritic Glycolytic
    High Mitochondrial Respiration and Glycolytic Capacity Represent a Metabolic Phenotype of Human Tolerogenic Dendritic Cells This information is current as of September 26, 2021. Frano Malinarich, Kaibo Duan, Raudhah Abdull Hamid, Au Bijin, Wu Xue Lin, Michael Poidinger, Anna-Marie Fairhurst and John E. Connolly J Immunol published online 27 April 2015 http://www.jimmunol.org/content/early/2015/04/25/jimmun Downloaded from ol.1303316 Supplementary http://www.jimmunol.org/content/suppl/2015/04/25/jimmunol.130331 http://www.jimmunol.org/ Material 6.DCSupplemental Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on September 26, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2015 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published April 27, 2015, doi:10.4049/jimmunol.1303316 The Journal of Immunology High Mitochondrial Respiration and Glycolytic Capacity Represent a Metabolic Phenotype of Human Tolerogenic Dendritic Cells Frano Malinarich,*,† Kaibo Duan,† Raudhah Abdull Hamid,*,† Au Bijin,*,† Wu Xue Lin,*,† Michael Poidinger,† Anna-Marie Fairhurst,† and John E.
    [Show full text]
  • MSK1 (RPS6KA5) (NM 004755) Human Tagged ORF Clone Product Data
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for RC220636L2 MSK1 (RPS6KA5) (NM_004755) Human Tagged ORF Clone Product data: Product Type: Expression Plasmids Product Name: MSK1 (RPS6KA5) (NM_004755) Human Tagged ORF Clone Tag: mGFP Symbol: RPS6KA5 Synonyms: MSK1; MSPK1; RLPK Vector: pLenti-C-mGFP (PS100071) E. coli Selection: Chloramphenicol (34 ug/mL) Cell Selection: None ORF Nucleotide The ORF insert of this clone is exactly the same as(RC220636). Sequence: Restriction Sites: SgfI-MluI Cloning Scheme: ACCN: NM_004755 ORF Size: 2406 bp This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 3 MSK1 (RPS6KA5) (NM_004755) Human Tagged ORF Clone – RC220636L2 OTI Disclaimer: The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info OTI Annotation: This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. RefSeq: NM_004755.2 RefSeq Size: 3883 bp RefSeq ORF: 2409 bp Locus ID: 9252 UniProt ID: O75582 Domains: pkinase, S_TK_X, TyrKc, S_TKc Protein Families: Druggable Genome, Protein Kinase, Transcription Factors Protein Pathways: Bladder cancer, MAPK signaling pathway, Neurotrophin signaling pathway MW: 89.7 kDa This product is to be used for laboratory only.
    [Show full text]
  • The Mtor Substrate S6 Kinase 1 (S6K1)
    The Journal of Neuroscience, July 26, 2017 • 37(30):7079–7095 • 7079 Cellular/Molecular The mTOR Substrate S6 Kinase 1 (S6K1) Is a Negative Regulator of Axon Regeneration and a Potential Drug Target for Central Nervous System Injury X Hassan Al-Ali,1,2,3* Ying Ding,5,6* Tatiana Slepak,1* XWei Wu,5 Yan Sun,5,7 Yania Martinez,1 Xiao-Ming Xu,5 Vance P. Lemmon,1,3 and XJohn L. Bixby1,3,4 1Miami Project to Cure Paralysis, University of Miami Miller School of Medicine, Miami, Florida 33136, 2Peggy and Harold Katz Family Drug Discovery Center, University of Miami Miller School of Medicine, Miami, Florida 33136, 3Department of Neurological Surgery, University of Miami Miller School of Medicine, Miami, Florida 33136, 4Department of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, Florida 33136, 5Spinal Cord and Brain Injury Research Group, Stark Neurosciences Research Institute, Department of Neurological Surgery, Indiana University School of Medicine, Indianapolis, Indiana 46202, 6Department of Histology and Embryology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong 510080, China, and 7Department of Anatomy, Histology and Embryology, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China Themammaliantargetofrapamycin(mTOR)positivelyregulatesaxongrowthinthemammaliancentralnervoussystem(CNS).Althoughaxon regeneration and functional recovery from CNS injuries are typically limited, knockdown or deletion of PTEN, a negative regulator of mTOR, increases mTOR activity and induces robust axon growth and regeneration. It has been suggested that inhibition of S6 kinase 1 (S6K1, gene symbol: RPS6KB1), a prominent mTOR target, would blunt mTOR’s positive effect on axon growth. In contrast to this expectation, we demon- strate that inhibition of S6K1 in CNS neurons promotes neurite outgrowth in vitro by twofold to threefold.
    [Show full text]
  • Hyperthermia Induces Therapeutic Effectiveness and Potentiates
    www.nature.com/scientificreports OPEN Hyperthermia induces therapeutic efectiveness and potentiates adjuvant therapy with non- Received: 21 February 2018 Accepted: 4 July 2018 targeted and targeted drugs in an Published: xx xx xxxx in vitro model of human malignant melanoma T. Mantso1,2, S. Vasileiadis3,4, I. Anestopoulos4, G. P. Voulgaridou4, E. Lampri5, S. Botaitis6, E. N. Kontomanolis3, C. Simopoulos6, G. Goussetis7, R. Franco8,9, K. Chlichlia 4, A. Pappa4 & M. I. Panayiotidis1,2 In the present study, we have aimed to characterize the intrinsic, extrinsic and ER-mediated apoptotic induction by hyperthermia in an in vitro model of human malignant melanoma and furthermore, to evaluate its therapeutic efectiveness in an adjuvant therapeutic setting characterized by combinational treatments with non-targeted (Dacarbazine & Temozolomide) and targeted (Dabrafenib & Vemurafenib) drugs. Overall, our data showed that both low (43 °C) and high (45 °C) hyperthermic exposures were capable of inducing cell death by activating all apoptotic pathways but in a rather distinct manner. More specifcally, low hyperthermia induced extrinsic and intrinsic apoptotic pathways both of which activated caspase 6 only as opposed to high hyperthermia which was mediated by the combined efects of caspases 3, 7 and 6. Furthermore, signifcant involvement of the ER was evident (under both hyperthermic conditions) suggesting its role in regulating apoptosis via activation of CHOP. Our data revealed that while low hyperthermia activated IRE-1 and ATF6 only, high hyperthermia induced activation of PERK as well suggesting that ultimately these ER stress sensors can lead to the induction of CHOP via diferent pathways of transmitted signals. Finally, combinational treatment protocols revealed an efect of hyperthermia in potentiating the therapeutic efectiveness of non- targeted as well as targeted drugs utilized in the clinical setting.
    [Show full text]
  • Transcription Factor -Catenin Plays a Key Role in Fluid Flow Shear Stress
    cells Article Transcription Factor β-Catenin Plays a Key Role in Fluid Flow Shear Stress-Mediated Glomerular Injury in Solitary Kidney Tarak Srivastava 1,2,3,*, Daniel P. Heruth 4 , R. Scott Duncan 5, Mohammad H. Rezaiekhaligh 1, Robert E. Garola 6, Lakshmi Priya 1, Jianping Zhou 2,7, Varun C. Boinpelly 2,7, Jan Novak 8, Mohammed Farhan Ali 1, Trupti Joshi 9,10,11,12, Uri S. Alon 1, Yuexu Jiang 10,11, Ellen T. McCarthy 13, Virginia J. Savin 7, Ram Sharma 7, Mark L. Johnson 3 and Mukut Sharma 2,7,13 1 Section of Nephrology, Children’s Mercy Hospital and University of Missouri at Kansas City, Kansas City, MO 64108, USA; [email protected] (M.H.R.); [email protected] (L.P.); [email protected] (M.F.A.); [email protected] (U.S.A.) 2 Midwest Veterans’ Biomedical Research Foundation (MVBRF), Kansas City, MO 64128, USA; [email protected] (J.Z.); [email protected] (V.C.B.); [email protected] (M.S.) 3 Department of Oral and Craniofacial Sciences, School of Dentistry, University of Missouri at Kansas City, Kansas City, MO 64108, USA; [email protected] 4 Children’s Mercy Research Institute, Children’s Mercy Hospital and University of Missouri at Kansas City, Kansas City, MO 64108, USA; [email protected] 5 School of Biological Sciences, University of Missouri at Kansas City, Kansas City, MO 64108, USA; [email protected] 6 Department of Pathology and Laboratory Medicine, Children’s Mercy Hospital and University of Missouri at Kansas City, Kansas City, MO 64108, USA; [email protected] 7 Kansas City VA Medical Center, Kansas City, MO 64128, USA; [email protected] (V.J.S.); Citation: Srivastava, T.; Heruth, D.P.; [email protected] (R.S.) 8 Duncan, R.S.; Rezaiekhaligh, M.H.; Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35487, USA; Garola, R.E.; Priya, L.; Zhou, J.; [email protected] 9 Department of Health Management and Informatics, University of Missouri, Columbia, MO 65211, USA; Boinpelly, V.C.; Novak, J.; Ali, M.F.; [email protected] et al.
    [Show full text]
  • PRODUCTS and SERVICES Target List
    PRODUCTS AND SERVICES Target list Kinase Products P.1-11 Kinase Products Biochemical Assays P.12 "QuickScout Screening Assist™ Kits" Kinase Protein Assay Kits P.13 "QuickScout Custom Profiling & Panel Profiling Series" Targets P.14 "QuickScout Custom Profiling Series" Preincubation Targets Cell-Based Assays P.15 NanoBRET™ TE Intracellular Kinase Cell-Based Assay Service Targets P.16 Tyrosine Kinase Ba/F3 Cell-Based Assay Service Targets P.17 Kinase HEK293 Cell-Based Assay Service ～ClariCELL™ ～ Targets P.18 Detection of Protein-Protein Interactions ～ProbeX™～ Stable Cell Lines Crystallization Services P.19 FastLane™ Structures ～Premium～ P.20-21 FastLane™ Structures ～Standard～ Kinase Products For details of products, please see "PRODUCTS AND SERVICES" on page 1～3. Tyrosine Kinases Note: Please contact us for availability or further information. Information may be changed without notice. Expression Protein Kinase Tag Carna Product Name Catalog No. Construct Sequence Accession Number Tag Location System HIS ABL(ABL1) 08-001 Full-length 2-1130 NP_005148.2 N-terminal His Insect (sf21) ABL(ABL1) BTN BTN-ABL(ABL1) 08-401-20N Full-length 2-1130 NP_005148.2 N-terminal DYKDDDDK Insect (sf21) ABL(ABL1) [E255K] HIS ABL(ABL1)[E255K] 08-094 Full-length 2-1130 NP_005148.2 N-terminal His Insect (sf21) HIS ABL(ABL1)[T315I] 08-093 Full-length 2-1130 NP_005148.2 N-terminal His Insect (sf21) ABL(ABL1) [T315I] BTN BTN-ABL(ABL1)[T315I] 08-493-20N Full-length 2-1130 NP_005148.2 N-terminal DYKDDDDK Insect (sf21) ACK(TNK2) GST ACK(TNK2) 08-196 Catalytic domain
    [Show full text]
  • The Regulatory Role of Meaib in Protein Metabolism and the Mtor Signaling Pathway in Porcine Enterocytes
    UC Davis UC Davis Previously Published Works Title The Regulatory Role of MeAIB in Protein Metabolism and the mTOR Signaling Pathway in Porcine Enterocytes. Permalink https://escholarship.org/uc/item/8nn544jf Journal International journal of molecular sciences, 19(3) ISSN 1422-0067 Authors Tang, Yulong Tan, Bie Li, Guangran et al. Publication Date 2018-03-02 DOI 10.3390/ijms19030714 Peer reviewed eScholarship.org Powered by the California Digital Library University of California International Journal of Molecular Sciences Article The Regulatory Role of MeAIB in Protein Metabolism and the mTOR Signaling Pathway in Porcine Enterocytes Yulong Tang 1,2, Bie Tan 1,3,*, Guangran Li 1, Jianjun Li 1, Peng Ji 3 ID and Yulong Yin 1,* 1 Laboratory of Animal Nutritional Physiology and Metabolic Process, Key Laboratory of Agro-ecological Processes in Subtropical Region, National Engineering Laboratory for Pollution Control and Waste Utilization in Livestock and Poultry Production, Institute of Subtropical Agriculture, Chinese Academy of Sciences, Changsha 410125, China; [email protected] (Y.T.); [email protected] (G.L.); [email protected] (J.L.) 2 Hunan Co-Innovation Center of Animal Production Safety (CICAPS), Changsha 410128, China 3 Department of Nutrition, University of California, Davis, CA 95616, USA; [email protected] * Correspondence: [email protected] (B.T.); [email protected] (Y.Y.); Tel.: +86-731-8461-9706 (Y.Y.) Received: 3 January 2018; Accepted: 28 February 2018; Published: 2 March 2018 Abstract: Amino acid transporters play an important role in cell growth and metabolism. MeAIB, a transporter-selective substrate, often represses the adaptive regulation of sodium-coupled neutral amino acid transporter 2 (SNAT2), which may act as a receptor and regulate cellular amino acid contents, therefore modulating cellular downstream signaling.
    [Show full text]
  • Oxidized Phospholipids Regulate Amino Acid Metabolism Through MTHFD2 to Facilitate Nucleotide Release in Endothelial Cells
    ARTICLE DOI: 10.1038/s41467-018-04602-0 OPEN Oxidized phospholipids regulate amino acid metabolism through MTHFD2 to facilitate nucleotide release in endothelial cells Juliane Hitzel1,2, Eunjee Lee3,4, Yi Zhang 3,5,Sofia Iris Bibli2,6, Xiaogang Li7, Sven Zukunft 2,6, Beatrice Pflüger1,2, Jiong Hu2,6, Christoph Schürmann1,2, Andrea Estefania Vasconez1,2, James A. Oo1,2, Adelheid Kratzer8,9, Sandeep Kumar 10, Flávia Rezende1,2, Ivana Josipovic1,2, Dominique Thomas11, Hector Giral8,9, Yannick Schreiber12, Gerd Geisslinger11,12, Christian Fork1,2, Xia Yang13, Fragiska Sigala14, Casey E. Romanoski15, Jens Kroll7, Hanjoong Jo 10, Ulf Landmesser8,9,16, Aldons J. Lusis17, 1234567890():,; Dmitry Namgaladze18, Ingrid Fleming2,6, Matthias S. Leisegang1,2, Jun Zhu 3,4 & Ralf P. Brandes1,2 Oxidized phospholipids (oxPAPC) induce endothelial dysfunction and atherosclerosis. Here we show that oxPAPC induce a gene network regulating serine-glycine metabolism with the mitochondrial methylenetetrahydrofolate dehydrogenase/cyclohydrolase (MTHFD2) as a cau- sal regulator using integrative network modeling and Bayesian network analysis in human aortic endothelial cells. The cluster is activated in human plaque material and by atherogenic lipo- proteins isolated from plasma of patients with coronary artery disease (CAD). Single nucleotide polymorphisms (SNPs) within the MTHFD2-controlled cluster associate with CAD. The MTHFD2-controlled cluster redirects metabolism to glycine synthesis to replenish purine nucleotides. Since endothelial cells secrete purines in response to oxPAPC, the MTHFD2- controlled response maintains endothelial ATP. Accordingly, MTHFD2-dependent glycine synthesis is a prerequisite for angiogenesis. Thus, we propose that endothelial cells undergo MTHFD2-mediated reprogramming toward serine-glycine and mitochondrial one-carbon metabolism to compensate for the loss of ATP in response to oxPAPC during atherosclerosis.
    [Show full text]